Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 16, 2024 - Alvotech and Teva announced the FDA approval of Selarsdi (ustekinumab-aekn), biosimilar to Janssen’s Stelara® (ustekinumab).
Download PDF
Return to publications
